"Oral cancer has a very high incidence. Almost 89% of oral cancers in India arise from oral potentially malignant lesions of the oral cavity. But, not all potentially malignant lesions turn malignant. As a clinician of more than 30 years of experience, I still have a problem to deciding when to take a biopsy, from where to take a biopsy. In lesions like OSMF the entire oral cavity is involved. Definitely, the non-invasive imaging system will help clinicians like us in deciding where to take a biopsy from and when to take a biopsy and how often potentially malignant lesions have been involved. I hope the OralScan will be of benefit to the clinicians and the patients. "
Dr Anita Balan, MDS
Principal, Government Dental College (GDC), Thiruvananthapuram
"OralScan is an interesting and promising device. In one of our patients who was provisionally diagnosed with an ulcer on the upper right posterior ridge on a second biopsy following OralScan examination showed high DR ratio values for oxygenated haemoglobin absorption. Histopathological examination following guided biopsy with OralScan diagnosed the lesion as well differentiated SCC, which shows the promising potential of the device in identifying lesions noninvasively. "
Dr Sanjay C J, MDS
Department of Oral Medicine, JSS Dental College & Hospital, Mysuru
"I have been using this device for the past 6 months. If a white lesion is seen, OralScan can be used to identify which part of it is more aggressive and take a selected biopsy from that part for histopathological examination. People are taking biopsy from wrong places and cannot identify the right place. So this device will guide you to which site is malignant or not. We are using it for the last 6 months and are satisfied with it. OralScan® is going to create a big change in the future. It can screen cancer, prevent cancer and can help diagnose cancer with improved accuracy".
Dr. Radhamadhab Sahu, MS
Consultant – ENT & Skull Base Surgery, IMS and SUM Hospital, Bhubaneswar 751003, Orissa.
"We have been using the hand-held multispectral imaging device, OralScan® at COCPAR for the last 2 years. There is always a confusion in OPMD whether to do the biopsy or not, and if yes, in large lesions, from where to take a biopsy. We found the Oralcan to be of major use in decision making and also for determining the most malignant site for biopsy. With the use of OralScan® even inexperienced persons like healthcare workers can identify the malignancy resulting in early intervention and better prognosis. Even in OSCC, sometimes the clinician may have confusion regarding the site for biopsy. In such cases, OralScan can help the clinician to decide on the biopsy site, thereby preventing false negatives and repeat biopsies. In post treatment patients, OralScan is useful to identify local recurrences and prevent the trauma of multiple biopsies. The device is very useful in educating patients on the need for regular screenings and check-ups to prevent cancer, and why biopsy is mandatory in a lesion which is not yet cancerous."
Dr. Vidyarani Shyam Sundar, MDS
Centre for Oral Cancer Prevention Awareness and Research (COCPAR), Sree Balaji Dental College and Hospital, Pallikarani, Chennai, TN
“OralScan is first of a kind algorithm based intraoral screening device, which serves as a useful diagnostic adjuvant and can delineate the surgical margins during excision. The device is user friendly and can be used by any health care worker with little training.”
Prof (Dr.) Mahesh Datta Rao, MDS
Dept of Oral Medicine, Dayanand Sagar Dental College, Kumaraswamy Layout, Bengaluru, Karnataka 560078
“OralScan facilitates early detection of dysplastic changes and initiation of appropriate therapies as required. Given the rising burden of oral cancer in India, early detection may reduce treatment delays and save lives”
Dr Manju Mariam Stephen, MDS
Dept of Pathology, Government Dental College, Medical College P.O., Thiruvananthapuram – 695 012